None listed
Conditions
Interventions
Intervention1: Cookie: Dose: 500 mg of Calcium Carbonate
Frequency: once a day
Route of administration: Oral
Duration of intervention:12 weeks
Control Intervention1: Cookie: Dose:100 mg of Calcium
Sponsors
The New York Academy of Sciences.
Eligibility
Inclusion criteria
Inclusion criteria: Healthy children between 6 to 10 years old. Vitamin D 25OHD ( > 20ng/mL). Non-anaemic Hb >11.5.0 g/dL. Z score >- 2SD. Not taking any food supplements/fortified drinks. Not planning to move out during the study duration.
Exclusion criteria
Exclusion criteria: Age: 10 years Severe anemia (Hb <8g/dl) Severely malnourished children with weight for height Z score < -3SD Any food allergy or food intolerance Any metabolic, gastrointestinal kidney or chronic diseases such as diabetes, hepatitis, hypertension, cancer, or cardiovascular diseases (according to the participant’s statement) Continuous/long-term use of medication during the whole study Consumption of mineral and vitamin supplements within 2 weeks before the start of the study Blood transfusion, blood donation or significant blood loss (accident, surgery) over the past 4 months Earlier participation in any clinical study within the last 30 days A participant who cannot be expected to comply with the study protocol (e.g., not available on certain study appointments) Likely to move out of the study area within the period of the study intervention. Difficulties with blood samplinG.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the change in urinary calcium as a reliable biomarker for calcium status/bone mineralization in children in response to increased dietary calcium intake. Timepoint: Weeks 1,4,8,12 | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Prashanth Thankachan
St.Johns National Academy of Health Sciences
Outcome results
None listed